Skip to main content

Moleculin Biotech CS(MBRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Moleculin to Present at the H.C. Wainwright 24th Annual Global Investment Conference

PR Newswire - Wed Sep 7, 2022

HOUSTON, Sept. 7, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., ( Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter Klemp, President and Chief Executive Officer of Moleculin, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY and virtually on September 12-14, 2022.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe